speb/financial-data huggingface dataset:
CATO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.09
CATO balance_sheet (annual, 2026-01-31) — Taxes Receivable: 5739000.00
CATO balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 5739000.00
CATO balance_sheet (annual, 2026-01-31) — Total Assets: 421419000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Assets: 421419000.00
CATO balance_sheet (annual, 2026-01-31) — Total Capitalization: 157314000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 157314000.00
CATO balance_sheet (annual, 2026-01-31) — Total Debt: 150448000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Debt: 150448000.00
CATO balance_sheet (annual, 2026-01-31) — Total Equity Gross Minority Interest: 157314000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 157314000.00
CATO income_statement (annual, 2026-01-31) — Total Expenses: 667884000.00
CATO income_statement (quarterly, 2026-01-31) — Total Expenses: 165380000.00
CATO balance_sheet (annual, 2026-01-31) — Total Liabilities Net Minority Interest: 264105000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 264105000.00
CATO balance_sheet (annual, 2026-01-31) — Total Non Current Assets: 228152000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 228152000.00
CATO balance_sheet (annual, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 108213000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 108213000.00
CATO balance_sheet (annual, 2026-01-31) — Total Tax Payable: 11784000.00
CATO balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 11784000.00
CATO balance_sheet (annual, 2026-01-31) — Working Capital: 37375000.00
CATO balance_sheet (quarterly, 2026-01-31) — Working Capital: 37375000.00
CATO income_statement (quarterly, 2026-04-30) — +Operating Expense: 56166000.00
CATO income_statement (quarterly, 2026-04-30) — +Total Revenue: 171104000.00
CATO balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 79702000.00
CATO balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 33159000.00
CATO balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 131989000.00
CATO balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -676000.00
CATO cash_flow (quarterly, 2026-04-30) — Amortization Of Securities: -98000.00
CATO income_statement (quarterly, 2026-04-30) — Basic Average Shares: 19806383.00
CATO income_statement (quarterly, 2026-04-30) — Basic EPS: 0.47
CATO cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 19463000.00
CATO cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -1067000.00
CATO cash_flow (quarterly, 2026-04-30) — Capital Expenditure Reported: -1067000.00
CATO balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 145027000.00
CATO balance_sheet (quarterly, 2026-04-30) — Capital Stock: 674000.00
CATO balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 25412000.00
CATO balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 80970000.00
CATO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -234000.00
CATO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: 809000.00
CATO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 8049000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Account Payable: 13866000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Inventory: -8794000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -221000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Payable: 13866000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 13866000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -390000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Receivables: -8642000.00
CATO cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -4181000.00
CATO cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: -8642000.00
CATO cash_flow (quarterly, 2026-04-30) — Changes In Cash: 8624000.00
CATO balance_sheet (quarterly, 2026-04-30) — Common Stock: 674000.00
CATO balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 166705000.00
CATO cash_flow (quarterly, 2026-04-30) — Common Stock Payments: -311000.00
CATO income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 106340000.00
CATO balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 36428000.00
CATO balance_sheet (quarterly, 2026-04-30) — Current Assets: 217222000.00
CATO balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 52088000.00
CATO balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 52088000.00
CATO balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 168218000.00
CATO cash_flow (quarterly, 2026-04-30) — Depreciation: 2236000.00
CATO cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 2236000.00
CATO income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 2236000.00
CATO cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 2236000.00
CATO income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 2236000.00
CATO income_statement (quarterly, 2026-04-30) — Depreciation Income Statement: 2236000.00
CATO income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 19806383.00
CATO income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.47
CATO income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — EBIT: 8598000.00
CATO income_statement (quarterly, 2026-04-30) — EBITDA: 10834000.00
CATO cash_flow (quarterly, 2026-04-30) — End Cash Position: 28087000.00
CATO cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -234000.00
CATO balance_sheet (quarterly, 2026-04-30) — Finished Goods: 92490000.00
CATO cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 6982000.00
CATO cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of PPE: -2000.00
CATO balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 14000.00
CATO balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 33835000.00
CATO balance_sheet (quarterly, 2026-04-30) — Gross PPE: 201238000.00
CATO income_statement (quarterly, 2026-04-30) — Gross Profit: 64764000.00
CATO income_statement (quarterly, 2026-04-30) — Interest Income: 1233000.00
CATO income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 1233000.00
CATO balance_sheet (quarterly, 2026-04-30) — Inventory: 92490000.00
CATO balance_sheet (quarterly, 2026-04-30) — Invested Capital: 166705000.00
CATO cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: 809000.00
CATO balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 92939000.00
CATO balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 92939000.00
CATO cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -311000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 9309000.00
CATO cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 9309000.00
CATO income_statement (quarterly, 2026-04-30) — Net Interest Income: 1233000.00
CATO cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 1138000.00
CATO income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 1233000.00
CATO cash_flow (quarterly, 2026-04-30) — Net Other Investing Changes: 738000.00
CATO balance_sheet (quarterly, 2026-04-30) — Net PPE: 201238000.00
CATO balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 166705000.00
CATO income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 10834000.00
CATO income_statement (quarterly, 2026-04-30) — Normalized Income: 9309000.00
CATO cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 8049000.00
CATO cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -2000.00
CATO income_statement (quarterly, 2026-04-30) — Operating Income: 8598000.00
CATO income_statement (quarterly, 2026-04-30) — Operating Revenue: 169410000.00
CATO balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 19958858.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 7928000.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: 14000.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 20720000.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 11318000.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Properties: 201238000.00
CATO balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 55558000.00
CATO income_statement (quarterly, 2026-04-30) — Otherunder Preferred Stock Dividend: 427000.00
CATO balance_sheet (quarterly, 2026-04-30) — Payables: 79702000.00
CATO balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 116130000.00
CATO balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
CATO income_statement (quarterly, 2026-04-30) — Pretax Income: 9831000.00
CATO cash_flow (quarterly, 2026-04-30) — Proceeds From Stock Option Exercised: 77000.00
CATO cash_flow (quarterly, 2026-04-30) — Provisionand Write Offof Assets: 207000.00
CATO cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -6836000.00
CATO balance_sheet (quarterly, 2026-04-30) — Receivables: 33159000.00
CATO income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 106340000.00
CATO income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 2236000.00
CATO cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: -311000.00
CATO balance_sheet (quarterly, 2026-04-30) — Restricted Cash: 2675000.00
CATO balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 34028000.00
CATO cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 7974000.00
CATO income_statement (quarterly, 2026-04-30) — Selling General And Administration: 53930000.00
CATO balance_sheet (quarterly, 2026-04-30) — Share Issued: 19958858.00
CATO cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 578000.00
CATO balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 166705000.00
CATO balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 166705000.00
CATO income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
CATO income_statement (quarterly, 2026-04-30) — Tax Provision: 522000.00
CATO income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.05
CATO balance_sheet (quarterly, 2026-04-30) — Total Assets: 439180000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 166705000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Debt: 145027000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 166705000.00
CATO income_statement (quarterly, 2026-04-30) — Total Expenses: 162506000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 272475000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 221958000.00
CATO balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 104257000.00
CATO balance_sheet (quarterly, 2026-04-30) — Working Capital: 49004000.00
CATR.TO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CATR.TO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 135000000.00
CATR.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
CATR.TO income_statement (annual, 2021-12-31) — Interest Income: 80000000.00
CATR.TO income_statement (annual, 2021-12-31) — Interest Income Non Operating: 80000000.00
CATR.TO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 135000000.00
CATR.TO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -4000000.00
CATR.TO balance_sheet (annual, 2021-12-31) — Other Receivables: 8898000000.00
CATR.TO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 2788000000.00
CATR.TO cash_flow (annual, 2021-12-31) — Sale Of Business: 36000000.00
CATR.TO income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
CATR.TO income_statement (annual, 2022-12-31) — +Operating Expense: 8683000000.00
CATR.TO income_statement (annual, 2022-12-31) — +Total Revenue: 59427000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 8689000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 17869000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -16036000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 925000000.00
CATR.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 9716330720.00
CATR.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.69
CATR.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 9263000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 7016000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -2599000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -2599000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: -112000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 6560000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7004000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 7004000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -2440000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -7281000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2541000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 7766000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 798000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 407000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -2589000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -210000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -754000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 768000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Payable: 798000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1205000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -220000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -1800000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -2056000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Commercial Paper: 5455000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Common Stock: 6560000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -2440000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 15869000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 51000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -4230000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 1020000000.00
CATR.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 41915000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6393000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Assets: 43785000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Debt: 11279000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 11279000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 1860000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 1860000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 31531000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Current Notes Payable: 502000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -377000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -377000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2219000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2219000000.00
CATR.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 9780872677.00
CATR.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.69
CATR.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6705000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Dividends Payable: 620000000.00
CATR.TO income_statement (annual, 2022-12-31) — EBIT: 9195000000.00
CATR.TO income_statement (annual, 2022-12-31) — EBITDA: 11414000000.00
CATR.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 19000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -194000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Employee Benefits: 4203000000.00
CATR.TO cash_flow (annual, 2022-12-31) — End Cash Position: 7013000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -7281000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 8138000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 5167000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CATR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 215000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -2457000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Goodwill: 5288000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6046000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 28064000000.00
CATR.TO income_statement (annual, 2022-12-31) — Gross Profit: 17512000000.00
CATR.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 925000000.00
CATR.TO income_statement (annual, 2022-12-31) — Interest Expense: 443000000.00
CATR.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 443000000.00
CATR.TO income_statement (annual, 2022-12-31) — Interest Income: 167000000.00
CATR.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 167000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Inventory: 16270000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 52974000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2541000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 51000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6674000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 622000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: -112000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 25826000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 25714000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6674000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -7728000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 13838000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 22000000.00
CATR.TO income_statement (annual, 2022-12-31) — Minority Interests: 1000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 1000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -4179000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Net Debt: 30101000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income: 6705000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6705000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6704000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6705000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6705000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6704000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6704000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Interest Income: -443000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -782000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -652000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1054000000.00
CATR.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -443000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -10000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 9000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Net PPE: 12028000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 830000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 402000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 9823000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 13278000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 2213000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2213000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 4203000000.00
CATR.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 12124000000.00
CATR.TO income_statement (annual, 2022-12-31) — Normalized Income: 7247440000.00
CATR.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 7766000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -606000000.00
CATR.TO income_statement (annual, 2022-12-31) — Operating Income: 8829000000.00
CATR.TO income_statement (annual, 2022-12-31) — Operating Revenue: 59427000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 516345490.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 2642000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 5322000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 2690000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -2457000000.00
CATR.TO income_statement (annual, 2022-12-31) — Other Income Expense: 366000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 758000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 701000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4593000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 4604000000.00
CATR.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1076000000.00
CATR.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 1218000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Other Properties: 5568000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Payables: 9309000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 15702000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: -606000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2642000000.00
CATR.TO income_statement (annual, 2022-12-31) — Pretax Income: 8752000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
CATR.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -3165000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 6680000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Receivables: 17869000000.00
CATR.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 41915000000.00
CATR.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2219000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -7728000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -4230000000.00
CATR.TO income_statement (annual, 2022-12-31) — Research And Development: 1814000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 43514000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 1000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 2383000000.00
CATR.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 830000000.00
CATR.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 5651000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Share Issued: 814894624.00
CATR.TO income_statement (annual, 2022-12-31) — Special Income Charges: -925000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 15869000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 9823000000.00
CATR.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -167560000.00
CATR.TO income_statement (annual, 2022-12-31) — Tax Provision: 2067000000.00
CATR.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
CATR.TO balance_sheet (annual, 2022-12-31) — Total Assets: 81943000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 41695000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Debt: 36993000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 15891000000.00
CATR.TO income_statement (annual, 2022-12-31) — Total Expenses: 50598000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 66052000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 38158000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 34521000000.00
CATR.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 7904000000.00
CATR.TO income_statement (annual, 2022-12-31) — Total Unusual Items: -710000000.00
CATR.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -710000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 298549134.00
CATR.TO balance_sheet (annual, 2022-12-31) — Treasury Stock: 31748000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Work In Process: 1452000000.00
CATR.TO balance_sheet (annual, 2022-12-31) — Working Capital: 12254000000.00
CATR.TO income_statement (annual, 2023-12-31) — +Operating Expense: 10297000000.00
CATR.TO income_statement (annual, 2023-12-31) — +Total Revenue: 67060000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 7906000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 18820000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -15943000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CATR.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 9415749602.00
CATR.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.10
CATR.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7013000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 7154000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -3092000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -3092000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: -61000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 6403000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 6978000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 6978000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -2563000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -6932000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5871000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 12885000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -754000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1282000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -364000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -95000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 439000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 80000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Payable: -754000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 528000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -437000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 151000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 82000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Commercial Paper: 4069000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Common Stock: 6403000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -2563000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 19494000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 12000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -4975000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 1259000000.00
CATR.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 43797000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7715000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Assets: 46949000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Debt: 13406000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 13406000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 1929000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 1929000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 34728000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Current Notes Payable: 574000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -592000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -592000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2144000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2144000000.00
CATR.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 9471071280.00
CATR.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.09
CATR.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 10335000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Dividends Payable: 649000000.00
CATR.TO income_statement (annual, 2023-12-31) — EBIT: 13561000000.00
CATR.TO income_statement (annual, 2023-12-31) — EBITDA: 15705000000.00
CATR.TO income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 63000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -110000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Employee Benefits: 4098000000.00
CATR.TO cash_flow (annual, 2023-12-31) — End Cash Position: 6985000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -6932000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 8308000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 9793000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 572000000.00
CATR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 409000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1820000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Goodwill: 5308000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5872000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 28623000000.00
CATR.TO income_statement (annual, 2023-12-31) — Gross Profit: 23263000000.00
CATR.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CATR.TO income_statement (annual, 2023-12-31) — Interest Expense: 511000000.00
CATR.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 511000000.00
CATR.TO income_statement (annual, 2023-12-31) — Interest Income: 494000000.00
CATR.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 494000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Inventory: 16565000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 57433000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5871000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 12000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 8257000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 616000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: -61000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 24533000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 24472000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 8257000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -6318000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 13757000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 9000000.00
CATR.TO income_statement (annual, 2023-12-31) — Minority Interests: 3000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -4000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -4963000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Net Debt: 30961000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income: 10335000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 10335000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 10332000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 10335000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 10335000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 10332000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 10332000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Interest Income: -511000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -2589000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 594000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1939000000.00
CATR.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -511000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -967000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Net PPE: 12680000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 781000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -1345000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 13622000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 13902000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 2816000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 2816000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 4098000000.00
CATR.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 15296000000.00
CATR.TO income_statement (annual, 2023-12-31) — Normalized Income: 10013117000.00
CATR.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 12885000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 475000000.00
CATR.TO income_statement (annual, 2023-12-31) — Operating Income: 12966000000.00
CATR.TO income_statement (annual, 2023-12-31) — Operating Revenue: 67060000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 499377269.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 4586000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 8763000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 3123000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1820000000.00
CATR.TO income_statement (annual, 2023-12-31) — Other Income Expense: 595000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 564000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 375000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 5257000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 4675000000.00
CATR.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 186000000.00
CATR.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 1818000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Other Properties: 5837000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Payables: 8555000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 16270000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -97000000.00
CATR.TO income_statement (annual, 2023-12-31) — Pretax Income: 13050000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
CATR.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -4000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -4480000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 6846000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Receivables: 18820000000.00
CATR.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 43797000000.00
CATR.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2144000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -6318000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -4975000000.00
CATR.TO income_statement (annual, 2023-12-31) — Research And Development: 2108000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: 51250000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 1891000000.00
CATR.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 781000000.00
CATR.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 6371000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Share Issued: 814894624.00
CATR.TO income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CATR.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 19494000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 13622000000.00
CATR.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 87117000.00
CATR.TO income_statement (annual, 2023-12-31) — Tax Provision: 2781000000.00
CATR.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CATR.TO balance_sheet (annual, 2023-12-31) — Total Assets: 87476000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 44027000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Debt: 37878000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 19503000000.00
CATR.TO income_statement (annual, 2023-12-31) — Total Expenses: 54094000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 67973000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 40527000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 33245000000.00
CATR.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 12966000000.00
CATR.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 409000000.00
CATR.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 409000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 315517355.00
CATR.TO balance_sheet (annual, 2023-12-31) — Treasury Stock: 36339000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Work In Process: 1411000000.00
CATR.TO balance_sheet (annual, 2023-12-31) — Working Capital: 12221000000.00
CATR.TO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 7000000.00
CATR.TO income_statement (quarterly, 2024-09-30) — Interest Income: 108000000.00
CATR.TO income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 108000000.00
CATR.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 7000000.00
CATR.TO cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 0.00
CATR.TO cash_flow (quarterly, 2024-09-30) — Purchase Of Business: -6000000.00
CATR.TO income_statement (annual, 2024-12-31) — +Operating Expense: 10252000000.00
CATR.TO income_statement (annual, 2024-12-31) — +Total Revenue: 64809000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 7675000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 18847000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -16116000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -16116000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CATR.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 8975020234.00
CATR.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 8851468486.00
CATR.TO income_statement (annual, 2024-12-31) — Basic EPS: 1.20
CATR.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.32
CATR.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 6985000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 7281000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 7281000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -3215000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -3215000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: -103000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: -103000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 6941000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6889000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 6889000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -2646000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -9565000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2453000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 12035000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: -282000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -172000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -414000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -97000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -104000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 370000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Payable: -282000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -454000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -160000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -859000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 17000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Commercial Paper: 3946000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Commercial Paper: 3946000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Common Stock: 6941000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -2646000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 19491000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 20000000.00
CATR.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 5000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -7697000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 1751000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1751000000.00
CATR.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 41485000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7634000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Assets: 45682000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Debt: 11058000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 11058000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 2322000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 2322000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 32272000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Current Notes Payable: 447000000.00
CATR.TO balance_sheet (quarterly, 2024-12-31) — Current Notes Payable: 447000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -621000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -621000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2153000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2153000000.00
CATR.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 9024809744.00
CATR.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 8899413941.00
CATR.TO income_statement (annual, 2024-12-31) — Diluted EPS: 1.20
CATR.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.31
CATR.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 10792000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 674000000.00
CATR.TO income_statement (annual, 2024-12-31) — EBIT: 13885000000.00
CATR.TO income_statement (annual, 2024-12-31) — EBITDA: 16038000000.00
CATR.TO income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: 44000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -106000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Employee Benefits: 3757000000.00
CATR.TO cash_flow (annual, 2024-12-31) — End Cash Position: 6896000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -9565000000.00
CATR.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 8329000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 8820000000.00
CATR.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 164000000.00
CATR.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CATR.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 592000000.00